Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.13
-0.0100-0.24%
Volume:438.34K
Turnover:1.89M
Market Cap:306.46M
PE:-1.81
High:4.75
Open:4.57
Low:4.10
Close:4.14
Loading ...

Olema Pharmaceuticals Inc - Phase 1 Clinical Trial for Op-3136 to Start Early 2025

THOMSON REUTERS
·
09 Dec 2024

Olema Oncology Announces FDA Clearance of Investigational New Drug Application for Op-3136, a Potent Kat6 Inhibitor

THOMSON REUTERS
·
09 Dec 2024

Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion

Zacks
·
04 Dec 2024

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

MT Newswires Live
·
02 Dec 2024

Olema Partners With Novartis for Clinical Trial of Potential Breast Cancer Drug, Launches $250 Million Stock, Warrant Placement

MT Newswires Live
·
02 Dec 2024

BRIEF-Olema Oncology Announces New Clinical Trial Collaboration And Supply Agreement With Novartis In Frontline Metastatic Breast Cancer As Well As $250 Million Equity Private Placement

Reuters
·
02 Dec 2024

Press Release: Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement

Dow Jones
·
02 Dec 2024

Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement With Novartis in Frontline Metastatic Breast Cancer as Well as $250 Million Equity Private Placement

THOMSON REUTERS
·
02 Dec 2024

Olema Pharmaceuticals Inc - Well Capitalized to Fund Operations Beyond Key Milestones

THOMSON REUTERS
·
02 Dec 2024

Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium

GlobeNewswire
·
26 Nov 2024

Press Release: Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Dow Jones
·
25 Nov 2024

Optimistic Buy Rating for Olema Pharmaceuticals Driven by Promising Developments with Palazestrant and Novartis Collaboration

TIPRANKS
·
22 Nov 2024

J.P. Morgan Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
21 Nov 2024

U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Reuters
·
20 Nov 2024

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

TD Cowen Sticks to Its Buy Rating for Olema Pharmaceuticals (OLMA)

TIPRANKS
·
13 Nov 2024